These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38049240)

  • 1. [Not Available].
    Galactéros F
    Rev Med Interne; 2023 Nov; 44(4S1):4S1. PubMed ID: 38049240
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain.
    Taylor JG; Nolan VG; Mendelsohn L; Kato GJ; Gladwin MT; Steinberg MH
    PLoS One; 2008 May; 3(5):e2095. PubMed ID: 18461136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between hemolysis and albuminuria in adults with sickle cell anemia.
    Day TG; Drasar ER; Fulford T; Sharpe CC; Thein SL
    Haematologica; 2012 Feb; 97(2):201-5. PubMed ID: 21993677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle cell anemia and vascular dysfunction: the nitric oxide connection.
    Akinsheye I; Klings ES
    J Cell Physiol; 2010 Sep; 224(3):620-5. PubMed ID: 20578237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPIKING ACID HYPERPHOSPHATASIA, SPLENOMEGALY, AND LEUKEMOID REACTION DURING A HEMOLYTIC SICKLE CELL CRISIS.
    SCHOENFELD MR
    J Mt Sinai Hosp N Y; 1964; 31():212-7. PubMed ID: 14167678
    [No Abstract]   [Full Text] [Related]  

  • 6. Heme-mediated cell activation: the inflammatory puzzle of sickle cell anemia.
    Guarda CCD; Santiago RP; Fiuza LM; Aleluia MM; Ferreira JRD; Figueiredo CVB; Yahouedehou SCMA; Oliveira RM; Lyra IM; Gonçalves MS
    Expert Rev Hematol; 2017 Jun; 10(6):533-541. PubMed ID: 28482712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EFFECT OF A CARBONIC ANHYDRASE INHIBITOR (DICHLORPHENAMIDE) ON SICKLE CELL ANEMIA.
    FINNEY RA; HATCH FE
    Am J Med Sci; 1965 Aug; 250():154-61. PubMed ID: 14331945
    [No Abstract]   [Full Text] [Related]  

  • 8. The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe.
    Nouraie M; Lee JS; Zhang Y; Kanias T; Zhao X; Xiong Z; Oriss TB; Zeng Q; Kato GJ; Gibbs JS; Hildesheim ME; Sachdev V; Barst RJ; Machado RF; Hassell KL; Little JA; Schraufnagel DE; Krishnamurti L; Novelli E; Girgis RE; Morris CR; Rosenzweig EB; Badesch DB; Lanzkron S; Castro OL; Goldsmith JC; Gordeuk VR; Gladwin MT;
    Haematologica; 2013 Mar; 98(3):464-72. PubMed ID: 22983573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa.
    Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B
    Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactate dehydrogenase and hemolysis in sickle cell disease.
    Kato GJ; Nouraie SM; Gladwin MT
    Blood; 2013 Aug; 122(6):1091-2. PubMed ID: 23929841
    [No Abstract]   [Full Text] [Related]  

  • 11. Massive hemolysis during sickle cell crisis.
    Parker DL; Parker JM; Stoltzfus GB
    Ohio State Med J; 1969 May; 65(5):495-6. PubMed ID: 4891298
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperhemolysis in sickle cell disease.
    Aragona E; Kelly MJ
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):e54-6. PubMed ID: 23619113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasculature and kidney complications in sickle cell disease.
    Nath KA; Katusic ZS
    J Am Soc Nephrol; 2012 May; 23(5):781-4. PubMed ID: 22440903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HUMAN ERYTHROCYTE CATALASE: DEMONSTRATION OF HETEROGENEITY AND RELATIONSHIP TO ERYTHROCYTE AGEING IN VIVO.
    THORUP OA; CARPENTER JT; HOWARD P
    Br J Haematol; 1964 Oct; 10():542-50. PubMed ID: 14218456
    [No Abstract]   [Full Text] [Related]  

  • 15. Point-of-care end-tidal carbon monoxide reflects severity of hemolysis in sickle cell anemia.
    Lal A; Patterson L; Goldrich A; Marsh A
    Pediatr Blood Cancer; 2015 May; 62(5):912-4. PubMed ID: 25683629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemia.
    Maier-Redelsperger M; Lévy P; Lionnet F; Stankovic K; Haymann JP; Lefèvre G; Avellino V; Perol JP; Girot R; Elion J
    Blood Cells Mol Dis; 2010 Dec; 45(4):289-92. PubMed ID: 20833087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle cell anemia-associated pulmonary arterial hypertension.
    Machado RF
    J Bras Pneumol; 2007; 33(5):583-91. PubMed ID: 18026658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium, glutathione peroxidase and oxidative hemolysis in sickle cell disease.
    Fujii S; Kaneko T
    Acta Haematol; 1992; 87(1-2):105-6. PubMed ID: 1585763
    [No Abstract]   [Full Text] [Related]  

  • 19. [Not Available].
    Bartolucci P
    Rev Med Interne; 2023 Nov; 44(4S1):4S7-4S11. PubMed ID: 38049244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.
    Kato GJ; Gladwin MT; Steinberg MH
    Blood Rev; 2007 Jan; 21(1):37-47. PubMed ID: 17084951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.